We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+11.96%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.1B
AUM Growth
+$1.16B
Cap. Flow
-$151M
Cap. Flow %
-1.49%
Top 10 Hldgs %
46.75%
Holding
616
New
9
Increased
46
Reduced
197
Closed
62

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.4M
2
PAYC icon
Paycom
PAYC
+$10.8M
3
VEEV icon
Veeva Systems
VEEV
+$9.74M
4
PH icon
Parker-Hannifin
PH
+$4.8M
5
WEX icon
WEX
WEX
+$4.15M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$50.9M
2
MA icon
Mastercard
MA
+$21.1M
3
EW icon
Edwards Lifesciences
EW
+$19.4M
4
MSFT icon
Microsoft
MSFT
+$12.3M
5
AAPL icon
Apple
AAPL
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 39.56%
2 Healthcare 17.19%
3 Financials 10.67%
4 Consumer Discretionary 10.19%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLYVK icon
451
Liberty Live Group Series C
LLYVK
$9.85B
$23.9K ﹤0.01%
642
– –
SPOT icon
452
Spotify
SPOT
$101B
$23.7K ﹤0.01%
110
– –
VTR icon
453
Ventas
VTR
$46.2B
$23.2K ﹤0.01%
500
– –
HLN icon
454
Haleon
HLN
$43.1B
$22.3K ﹤0.01%
2,725
-7,416
-73% -$61.1K
USO icon
455
United States Oil Fund
USO
$1.76B
$22.3K ﹤0.01%
315
-435
-58% -$31.5K
HBAN icon
456
Huntington Bancshares
HBAN
$36.3B
$22.3K ﹤0.01%
1,750
– –
EPAM icon
457
EPAM Systems
EPAM
$5.16B
$22.2K ﹤0.01%
80
– –
SWAV
458
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$21.5K ﹤0.01%
+95
New +$18K
AZN icon
459
AstraZeneca
AZN
$244B
$21.2K ﹤0.01%
159
– –
BABA icon
460
Alibaba
BABA
$295B
$21.1K ﹤0.01%
292
– –
BIDU icon
461
Baidu
BIDU
$35.3B
$21.1K ﹤0.01%
200
– –
KD icon
462
Kyndryl
KD
$2.89B
$20.8K ﹤0.01%
1,013
-507
-33% -$8.66K
IBB icon
463
iShares Biotechnology ETF
IBB
$9.82B
$20.2K ﹤0.01%
150
-217
-59% -$26.5K
LBRDA icon
464
Liberty Broadband Class A
LBRDA
$5.14B
$19.9K ﹤0.01%
256
– –
CSL icon
465
Carlisle Companies
CSL
$15B
$19.5K ﹤0.01%
62
-15
-19% -$4.13K
BNTX icon
466
BioNTech
BNTX
$23.2B
$18.1K ﹤0.01%
190
– –
FMS icon
467
Fresenius Medical Care
FMS
$12.6B
$17.9K ﹤0.01%
926
– –
EEM icon
468
iShares MSCI Emerging Markets ETF
EEM
$30.5B
$17.3K ﹤0.01%
450
– –
AAXJ icon
469
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
$17.2K ﹤0.01%
273
+2
+0.7% +$129
EGP icon
470
EastGroup Properties
EGP
$11B
$16.7K ﹤0.01%
94
– –
WTS icon
471
Watts Water Technologies
WTS
$12.8B
$16.6K ﹤0.01%
84
– –
PHO icon
472
Invesco Water Resources ETF
PHO
$2.05B
$16.6K ﹤0.01%
280
– –
DUK icon
473
Duke Energy
DUK
$96.7B
$16.1K ﹤0.01%
168
-115
-41% -$10.5K
RUN icon
474
Sunrun
RUN
$2.37B
$16.1K ﹤0.01%
1,111
– –
GHRS icon
475
GH Research
GHRS
$2.04B
$15.2K ﹤0.01%
2,000
– –
17 18
19
20 21

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 616 positions worth $10.1B, up 13% from $8.93B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2023 filing shows 9 new, 46 increased, 197 reduced and 62 closed positions. Its largest new stake was Keurig Dr Pepper: 6,000 shares worth $189K. The largest sale was Danaher, an estimated $50.9M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2023 buy was Keurig Dr Pepper: 6,000 shares worth $189K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q4 2023, an estimated $14.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2023 reduction was Danaher, cutting an estimated $50.9M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Amcor in Q4 2023, selling an estimated $1.02M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $10.1B portfolio in Q4 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 9 new positions and closed 62 in Q4 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 13% quarter-over-quarter to $10.1B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.